Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment-Reference-Cited by-同舟云学术

Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment

Published:2020-12-23 Issue:3 Volume:41 Page:464-469
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Kida Futa¹,Murayama Anju¹^ORCID,Saito Hiroaki¹²^ORCID,Ozaki Akihiko¹³,Shimada Yuki⁴,Tanimoto Tetsuya¹⁵

Affiliation:

1. Medical Governance Research Institute Tokyo Japan

2. Department of Gastroenterology Sendai Kousei Hospital Sendai Miyagi Japan

3. Department of Breast Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Fukushima Japan

4. Department of Neurosurgery Minamisoma Municipal General Hospital Minamisoma Fukushima Japan

5. Department of Internal Medicine Navitas Clinic Tachikawa, Tokyo Japan

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14761

Reference16 articles.

1. World Health Organization.Hepatitis C.https://www.who.int/news‐room/fact‐sheets/detail/hepatitis‐c. Published 2019. Updated July 27 2020. Accessed October 7 2020.

2. Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy

3. World Gastroenterology Organisation.World Gastroenterology Organisation Global Guidelines: Diagnosis Management and Prevention of Hepatitis C.https://www.spg.pt/wp‐content/uploads/2015/07/2017‐Hepatitis‐C.pdf. Published 2017. Accessed October 7 2020

4. Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries

5. Past, Present, and Future of Viral Hepatitis C in Japan

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis;BMJ Open;2024-07

2. Public preferences and willingness to pay for a net zero NHS: a protocol for a discrete choice experiment in England and Scotland;BMJ Open;2024-06

3. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan;BMJ Open;2024-06

4. Pharmaceutical company payments to Japanese breast cancer practice guideline authors;Clinical and Translational Discovery;2024-06

5. Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan;Journal of the American Heart Association;2024-04-16